Katey Wilson (Gabrysch) retweeted
🧠 Women’s Health in Multiple Sclerosis – Insights from Dr Riley Bove @BoveRiley - touchNEUROLOGY Future Leader 2025
In collaboration with the @mssociety, Dr Riley Bove (Associate Professor, UCSF Weill Institute for Neurosciences, San Francisco) shares her journey as a clinician-researcher dedicated to advancing understanding of brain health through the lens of neuroimmunology.
Focusing on the intersection of women’s health and multiple sclerosis, Dr Bove discusses the lifelong interplay between hormonal factors, environment, and neurological outcomes — and how evolving approaches in precision and digital phenotyping are shaping more holistic MS care.
📍 Read the full interview: touchneurology.com/insight/w…
#MultipleSclerosis #Neuroimmunology #WomensHealth #BrainHealth #MSResearch #Neurology
Katey Wilson (Gabrysch) retweeted
🧠 Meet Dr Alexander Lisinski, a touchNEUROLOGY Future Leader 2025. His work bridges clinical psychiatry and research, focusing on depression, psychopharmacology, and patient-centred care.
From his early experience in primary care to his PhD in psychopharmacology, Dr Lisinski highlights the impact of evidence-based treatments and the transformative potential of new therapies. He is particularly excited about:
✨ Psychedelic therapies – safely advancing these treatments for patients in Sweden.
✨ Next-generation antipsychotics – aiming for improved efficacy and fewer side effects.
✨ Patient-centred care – seeing the real-life benefits of thoughtful interventions.
🔗 Read interview:
touchneurology.com/insight/f…
#Psychiatry #MentalHealth @ifmadforum
Katey Wilson (Gabrysch) retweeted
🧠 “Stroke is now potentially a fully reversible condition. That shift is incredibly exciting.”
Vascular neurologist Dr Antonio Ciacciarelli @a_ciacciarelli shares his insights on stroke care, neuroprotection, and the value of mentorship in our latest Future Leader 2025 feature.
From bedside to bench, his work reflects a new era in neurology—where progress in ischaemic stroke and translational science is reshaping outcomes and perspectives.
🔗 touchneurology.com/insight/e…
#Stroke #ClinicalNeurology #VascularNeurology #Neurology #ESO #Cerebrovascular @ESOstroke
Katey Wilson (Gabrysch) retweeted
🧠 touchNEUROLOGY Future Leader 2025: Dr Bedia Samanci
We’re proud to spotlight Dr Bedia Samanci (Istanbul University) as a touchNEUROLOGY Future Leader 2025.
Her work is transforming neurodiagnostics through:
🧬 Biomarker discovery
🧠 Advanced neuroimaging
🤖 AI-driven diagnostics
In this inspiring Q&A, Dr Samanci reflects on mentorship, her passion for behavioural neurology, and why personalising care in neurodegeneration must be a priority.
📍 Read the full interview:
touchneurology.com/insight/s…
#FutureLeaders2025 #Neurodiagnostics #AIinNeurology #Parkinsons #Alzheimers
Katey Wilson (Gabrysch) retweeted
🧠 We’re proud to introduce Dr Sonu Bhaskar @DrSonuBhaskar as a touchNEUROLOGY Future Leader 2025!
An internationally recognised leader in vascular neurology, Dr Bhaskar is Founding Director of the NSW Brain Clot Bank and Global Health Neurology Lab. From stroke innovation to equitable care, he’s shaping the future of neurology—across Asia-Pacific and beyond.
Discover what drives his research, advocacy and vision for the next generation of neurologists.
🔗 Read now: touchneurology.com/insight/l…
#VascularNeurology #StrokeCare #FutureLeader2025 #GlobalHealth
Katey Wilson (Gabrysch) retweeted
📢 Closing the Gaps in Stroke Care: A Call to Action for Europe 🧠
Stroke remains Europe’s leading cause of neurological health loss, yet access to prevention, acute care, and rehabilitation is still uneven across the continent.
This October, policymakers, clinicians, and patient advocates gathered at the European Parliament in Brussels to discuss the Stroke Action Plan for Europe (SAPE)—a roadmap developed by the European Stroke Organisation @ESOstroke and Stroke Alliance for Europe @strokeeurope aimed at reducing stroke incidence, mortality, and disability by 2030.
Read more about this call to action and how Europe can close the gaps in stroke care 👉 touchneurology.com/insight/c…
#StrokeCare #Neurology #EUHealthPolicy #BrainHealth #ESO #SAFE #StrokeActionPlan #touchNEUROLOGY
It was a pleasure to meet Dr Antonella Marcerollo @anto_neurology to discuss her journey into neurology, her current research in #neuromodulation and a look to the future as a nominee in our Future Leaders programme for 2025
A really inspiring read! touchneurology.com/insight/a…
🧠 Advancing Neuromodulation with Dr Antonella Macerollo @anto_neurology – touchNEUROLOGY Future Leader 2025
Dr Antonella Macerollo, Consultant Neurologist at The Walton Centre NHS Foundation Trust and Honorary Clinical Associate Professor at the University of Liverpool, is driving innovation in movement disorders and advanced neuromodulation therapies.
In this Future Leader feature, supported by @ParkinsonsEU, Dr Macerollo shares her journey from early research in dystonia to pioneering work in deep brain stimulation (DBS) and MRI-guided focused ultrasound. She reflects on the mentors who shaped her career and her mission to improve access to neuromodulation services and reduce health inequalities in neurological care.
📍 Read the full interview: touchneurology.com/insight/a…
#Neuromodulation #MovementDisorders #DeepBrainStimulation #ParkinsonsDisease #BrainHealth #NeuroInnovation
24
Katey Wilson (Gabrysch) retweeted
🌍 #ESCMIDGlobal2025: Tackling Antibiotic Resistance
Dr Dariusz Hareza (Northwestern University, USA) highlights key insights from ESCMID Global 2025:
💡 Takeaways:
🔹Global action: Kazakhstan’s primary care AMR initiatives show local solutions matter.
🔹One Health: Resistance spreads across humans, animals, and environment – even migratory birds can carry resistant strains.
🔹Innovation: CRISPR and AI offer future tools for targeting resistance and outbreak response.
🔹Collaboration: Trusted global surveillance is essential for infectious disease control.
🔗 Full coverage: touchinfectiousdiseases.com/…
#AntimicrobialResistance #InfectiousDiseases #OneHealth #ESCMID2025
Katey Wilson (Gabrysch) retweeted
Have you listened to our latest #Podcast?
‘Bridging diagnostic and therapeutic gaps in Fabry disease management’
Listen now: touchpodcast.podbean.com/e/b…
#FabryDisease #RareDiseases #Genetics #CME #MedicalEducation #PatientCare
Katey Wilson (Gabrysch) retweeted
📢 Advances in Managing Agitation in Alzheimer’s Disease – AAIC 2025
Agitation is a challenging neuropsychiatric symptom in Alzheimer’s disease, contributing to caregiver burden and functional decline. At AAIC 2025, emerging insights highlighted how neurocircuitry and neurotransmitter imbalances drive these behaviours, and how targeted therapies are evolving.
Prof. George Grossberg explains how understanding prefrontal-amygdala connectivity and neurochemical changes is informing new approaches. Early diagnostic tools combined with symptom-focused treatments may soon allow more personalised care across the Alzheimer’s continuum.
Discover the latest developments and investigational therapies shaping the future of agitation management.
Read more: touchneurology.com/insight/a…
#AlzheimersDisease #Neuropsychiatry #AAIC2025 @alzassociation
Katey Wilson (Gabrysch) retweeted
🔔 Neurostimulation in Epilepsy: Current and Emerging Therapies
About one-third of epilepsy patients have drug-resistant seizures, and not all are candidates for surgery. Neurostimulation offers a valuable alternative, reducing seizure frequency and improving quality of life.
This comprehensive review explores options like vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation — plus emerging techniques including transcranial direct current stimulation and trigeminal nerve stimulation.
Read more: touchneurology.com/epilepsy/…
#Epilepsy #Neurostimulation #DeepBrainStimulation #EpilepsyTreatment
Katey Wilson (Gabrysch) retweeted
🧠 SOD1-ALS – From Discovery to Targeted Therapeutics
Over 30 years ago, mutations in superoxide dismutase 1 (SOD1) were first linked to familial amyotrophic lateral sclerosis (ALS). Today, SOD1-ALS remains one of the most common genetic forms of the disease.
This comprehensive review explores the journey from gene discovery to targeted therapies, including advances in antisense oligonucleotide approaches and ongoing research aimed at improving outcomes for people living with SOD1-ALS.
📄 Read the full article: touchneurology.com/brain-tra…
#ALS #SOD1 #Neurodegeneration #touchNEUROLOGY #NeurologyResearch
Katey Wilson (Gabrysch) retweeted
🧠 Future of Parkinson’s Treatment – Insights from EAN 2025
At the 2025 European Academy of Neurology (EAN) Congress, Prof. Joaquim Ferreira (University of Lisbon, Portugal) shared his expert perspective on the future of Parkinson’s disease care.
From the potential of gene therapies and stem cell research to the promise of adaptive deep brain stimulation (DBS), Prof. Ferreira highlights where progress is being made—and where key challenges remain. He also discusses strategies for managing persistent symptoms such as gait disturbance, dyskinesia, and cognitive decline.
Read interview:
🔗 touchneurology.com/insight/f…
#EAN2025 #ParkinsonsDisease #Neurology #DBS #GeneTherapy #touchNEUROLOGY
Katey Wilson (Gabrysch) retweeted
🦠 Get Infectious Disease Updates Straight to Your Inbox
We’re excited to launch our NEW Facebook Messenger Channel for healthcare professionals working in infectious diseases.
Stay informed with:
✅ Expert-led insights on AMR, emerging pathogens, HIV & more
✅ CME-accredited, bite-sized learning
✅ Clinical updates delivered wherever you are
📲 Join now and stay connected: messenger.com/channel/touchI…
#InfectiousDiseases #AMR #HIV #CME
Katey Wilson (Gabrysch) retweeted
🧠 EAN 2025 Highlights: Precision neurology in action
The European Academy of Neurology 2025 Congress brought major updates across five key areas:
🧩 Dementia
💥 Headache
🕊️ Movement disorders
🧬 Cerebrovascular disease
💪 Neuromuscular disease
From novel biomarkers to device-based interventions and therapeutic innovation, this year’s highlights reflect a future shaped by data-driven care and translational research.
🔍 Explore the highlights: touchneurology.com/insight/e…
#EAN2025 #Neurology #NeuroUpdates #Dementia #Migraine #Stroke #MS
It was great to speak with Dr @MarcelloMoccia_ about how the revised #McDonaldcriteria are changing MS diagnosis, and the growing role of #MRI, #OCT & biomarkers. #ECTRIMS25
🧠 Read the full Q&A: touchneurology.com/insight/i…
#MS #Neurology #Biomarkers #Imaging
🧠 Marcello Moccia @MarcelloMoccia_ on integrating imaging and biomarkers in the revised McDonald criteria
At ECTRIMS 2025, updates to the McDonald diagnostic criteria for multiple sclerosis (MS) emphasised a more flexible, multimodal approach — combining MRI, optical coherence tomography (OCT) and body-fluid biomarkers to enable earlier and more confident diagnoses.
Dr Moccia discusses how this adaptable framework can improve prognostication, treatment selection, and global equity of access to MS care, marking a significant step forward for clinicians and patients alike.
👉 Read the full interview: touchneurology.com/insight/i…
#ECTRIMS2025 #MultipleSclerosis #McDonaldCriteria #Neuroimaging #Biomarkers #MSResearch
Katey Wilson (Gabrysch) retweeted
🩺 On the Spot: Point-of-Care Testing for STIs
Rising STI rates are a growing global concern. In this episode of Visionary Voices, Dr Libby van Gerwen explains how point-of-care testing is helping clinicians identify and manage infections more quickly, improving patient outcomes. She also highlights the challenges and the potential of next-generation testing technologies to transform STI care.
Listen to the full discussion:
touchinfectiousdiseases.com/…
#STIs #PointOfCareTesting #InfectiousDiseases
Katey Wilson (Gabrysch) retweeted
🧠 Marcello Moccia @MarcelloMoccia_ on integrating imaging and biomarkers in the revised McDonald criteria
At ECTRIMS 2025, updates to the McDonald diagnostic criteria for multiple sclerosis (MS) emphasised a more flexible, multimodal approach — combining MRI, optical coherence tomography (OCT) and body-fluid biomarkers to enable earlier and more confident diagnoses.
Dr Moccia discusses how this adaptable framework can improve prognostication, treatment selection, and global equity of access to MS care, marking a significant step forward for clinicians and patients alike.
👉 Read the full interview: touchneurology.com/insight/i…
#ECTRIMS2025 #MultipleSclerosis #McDonaldCriteria #Neuroimaging #Biomarkers #MSResearch
Katey Wilson (Gabrysch) retweeted
🔬 Future Leader Spotlight: Dr Ikechukwu Benjamin Moses
“Bacteriophage therapy may be the next big step in reducing antibiotic dependence.”
Dr Moses, winner of the Emerging Young Investigator Award at ESCMID Global 2025, is exploring how AI, genomic sequencing, and phage gene cloning could transform antimicrobial resistance management. His work spans human–animal pathogen transmission and innovative strategies to reduce reliance on traditional antibiotics.
Discover how his lab-based research could shape real-world clinical solutions:
touchinfectiousdiseases.com/…
#AntimicrobialResistance #PhageTherapy
Katey Wilson (Gabrysch) retweeted
🦠 Who are infectious disease’s next generation of innovators and change-makers?
Get ready to find out the touchINFECTIOUSDISEASES Future Leaders 2025, celebrating exceptional early-career clinicians and researchers shaping the future of global infectious disease care.
👉 Register now for the official reveal: touchinfectiousdiseases.com/…
#FutureLeaders #InfectiousDiseases #GlobalHealth #AMR #Innovation






















